These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 5513211)
1. [X-ray inflammation irradiation in the therapy of venopathies and its complications]. Nikolowski W Z Haut Geschlechtskr; 1970 May; 45(10):403-6. PubMed ID: 5513211 [No Abstract] [Full Text] [Related]
2. [Therapy of venopathies from viewpoint the dermatologist's]. Schuster KH; Wolff E Z Allgemeinmed; 1975 Jan; 51(3):129-30. PubMed ID: 1130106 [No Abstract] [Full Text] [Related]
4. [Further pharmacologic possibilities in the therapy of phlebopathies of the lower limbs]. Bagliani A; Vittori F Clin Ter; 1972 May; 61(4):321-40. PubMed ID: 5065782 [No Abstract] [Full Text] [Related]
5. The treatment of chronic venous disorder of the leg. Allen S Practitioner; 1970 Aug; 205(226):221-4. PubMed ID: 5480515 [No Abstract] [Full Text] [Related]
6. [Clinical test of a new vascular eutrophic agent in phlebology]. Passas H Phlebologie; 1969; 22(2):219-24. PubMed ID: 5382253 [No Abstract] [Full Text] [Related]
7. [Drug therapy of venopathies]. Esser W Fortschr Med; 1975 Oct; 93(30):1506-7. PubMed ID: 1225812 [No Abstract] [Full Text] [Related]
8. [Apropos of the drug therapy of varicose disease with a new synthetic vitamin P]. Berson I Praxis; 1968 Aug; 57(34):1170-2. PubMed ID: 5756966 [No Abstract] [Full Text] [Related]
9. [Phlebological problems in the aged]. Guidi G G Gerontol; 1970 Jan; 18(1):29-35. PubMed ID: 5523120 [No Abstract] [Full Text] [Related]
10. [Social relevance of venous lymphatic diseases]. De Anna D; Corcos I Minerva Cardioangiol; 2002 Oct; 50(5 Suppl 1):34-8. PubMed ID: 12629481 [No Abstract] [Full Text] [Related]
11. [Etiopathogenic considerations in the treatment of venous insufficiency]. Hutinel B; Natali J Therapeutique; 1971 Oct; 47(8):733-6. PubMed ID: 5129924 [No Abstract] [Full Text] [Related]
12. Guidelines for the diagnosis and therapy of the vein and lymphatic disorders. Agus GB; Allegra C; Antignani PL; Arpaia G; Bianchini G; Bonadeo P; Botta G; Castaldi A; Gasbarro V; Genovese G; Georgiev M; Mancini S; Stillo F Int Angiol; 2005 Jun; 24(2):107-68. PubMed ID: 15997218 [No Abstract] [Full Text] [Related]
14. [Indications for corticotherapy in phlebology]. Chatard H Phlebologie; 1979; 32(4):375-82. PubMed ID: 545363 [TBL] [Abstract][Full Text] [Related]
15. Chronic venous disease. Bergan JJ; Schmid-Schönbein GW; Coleridge Smith PD; Nicolaides AN; Boisseau MR; Eklof B Minerva Cardioangiol; 2007 Aug; 55(4):459-76. PubMed ID: 17653022 [No Abstract] [Full Text] [Related]
16. [Clinical experiences with a vasoprotective drug in the treatment of venous problems of the lower limbs]. De Caprio M; Vinci L; Giumetti D; Colitta G Clin Ter; 1982 Jun; 101(5):497-508. PubMed ID: 6897029 [No Abstract] [Full Text] [Related]
17. [On prophylaxis by drug therapy and therapy of diseases of the veins in surgical and conservative orthopedics]. Hieber F Hippokrates; 1967 Apr; 38(8):319-20. PubMed ID: 5591018 [No Abstract] [Full Text] [Related]
18. [Conservative therapy in venous diseases]. Haid H Dtsch Med J; 1970 Apr; 21(7):453-6. PubMed ID: 5523429 [No Abstract] [Full Text] [Related]
19. [Clinical and rheographic studies of the activity of a phleboactive preparation in stasis ulcer]. Crosti C G Ital Dermatol Minerva Dermatol; 1971 Jun; 46(6):262-8. PubMed ID: 5109611 [No Abstract] [Full Text] [Related]
20. [Experiences with the new venous therapeutic agent, opino-gel]. Harrichhausen KH Ther Ggw; 1968 Apr; 107(4):549-52. PubMed ID: 5672327 [No Abstract] [Full Text] [Related] [Next] [New Search]